| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $656,964 | 5 | 100 |
Sells | $0 | 0 | 0 |
| Hargroves Thomas Jeffrey | director | 1 | $490,271 | 0 | $0 | $490,271 |
| Werth Peter J. | director | 1 | $98,053 | 0 | $0 | $98,053 |
| Schaffer Shane J. | Chief Executive Officer | 1 | $34,317 | 0 | $0 | $34,317 |
| Callahan Jennifer L. | SVP and CFO | 1 | $24,515 | 0 | $0 | $24,515 |
| Brams Matthew | EVP and Chief Medical Officer | 1 | $9,808 | 0 | $0 | $9,808 |
Cingulate Inc. is a biopharmaceutical enterprise currently in its clinical development phase, dedicated to devising therapeutic options for attention-deficit/hyperactivity disorder (ADHD). Leading its pipeline for ADHD are two drug candidates: CTx-1301 (dexmethylphenidate), which is currently progressing through Phase 3 clinical trials, and CTx-1302 (dextroamphetamine). The company is also engaged in the advancement of CTx-2103, a candidate intended for the management of anxiety disorders. Founded in 2012, Cingulate Inc. maintains its corporate …
Over the last 12 months, insiders at Cingulate Inc. have bought $656,964 and sold $0 worth of Cingulate Inc. stock.
On average, over the past 5 years, insiders at Cingulate Inc. have bought $677,408 and sold $11,525 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Hargroves Thomas Jeffrey (director) — $490,271. Werth Peter J. (director) — $98,053. Schaffer Shane J. (Chief Executive Officer) — $34,317.
The last purchase of 97,276 shares for transaction amount of $490,271 was made by Hargroves Thomas Jeffrey (director) on 2026‑02‑13.
| 2026-02-13 | Hargroves Thomas Jeffrey | director | 97,276 1.4576% | $5.04 | $490,271 | -14.83% | ||
| 2026-02-06 | Werth Peter J. | director | 19,455 0.2272% | $5.04 | $98,053 | -33.15% | ||
| 2026-02-06 | Schaffer Shane J. | Chief Executive Officer | 6,809 0.0795% | $5.04 | $34,317 | -33.15% | ||
| 2026-02-06 | Callahan Jennifer L. | SVP and CFO | 4,864 0.0568% | $5.04 | $24,515 | -33.15% | ||
| 2026-02-06 | Brams Matthew | EVP and Chief Medical Officer | 1,946 0.0227% | $5.04 | $9,808 | -33.15% | ||
| 2024-08-15 | Sale | Myers Laurie | EVP and COO | 202 0.0346% | $4.17 | $841 | -9.48% | |
| 2023-09-15 | Callahan Jennifer L. | Corporate Controller | 5,000 0.031% | $0.67 | $3,349 | -91.95% | ||
| 2023-08-11 | Werth Peter J. | director | 1.82M 16.1208% | $0.55 | $1M | -88.68% | ||
| 2023-05-15 | Callahan Jennifer L. | Corporate Controller | 2,000 0.0184% | $1.01 | $2,020 | -61.39% | ||
| 2023-05-12 | Callahan Jennifer L. | Corporate Controller | 4,000 0.0374% | $1.08 | $4,320 | -62.62% | ||
| 2022-12-16 | Schaffer Shane J. | Chief Executive Officer | 10,000 0.0879% | $1.02 | $10,166 | -11.54% | ||
| 2022-12-14 | Callahan Jennifer L. | Corporate Controller | 7,548 0.0728% | $0.99 | $7,468 | +0.16% | ||
| 2022-12-14 | Schaffer Shane J. | Chief Executive Officer | 13,267 0.1305% | $1.01 | $13,400 | +0.16% | ||
| 2022-12-13 | Werth Peter J. | director | 28,934 0.2505% | $0.98 | $28,422 | -9.36% | ||
| 2022-12-13 | Schaffer Shane J. | Chief Executive Officer | 1,733 0.0154% | $1.01 | $1,750 | -9.36% | ||
| 2022-11-29 | Callahan Jennifer L. | Corporate Controller | 1,530 0.0144% | $0.98 | $1,499 | +0.64% | ||
| 2022-11-28 | Callahan Jennifer L. | Corporate Controller | 3,487 0.0304% | $0.98 | $3,417 | -7.00% | ||
| 2022-11-23 | Myers Laurie | EVP and COO | 1,111 0.0098% | $0.90 | $1,000 | +2.74% | ||
| 2022-11-23 | Gilgallon Craig S. | EVP, GC and Secretary | 3,575 0.0295% | $0.84 | $3,003 | +2.74% | ||
| 2022-11-22 | GIVENS GREGG WM | director | 85,000 0.766% | $0.88 | $74,851 | +6.90% |
| Increased Positions | 13 | +118.18% | 257,578 | +88.72% |
| Decreased Positions | 5 | -45.45% | 34,537 | -11.9% |
| New Positions | 7 | New | 106,510 | New |
| Sold Out Positions | <1 | Sold Out | 10,772 | Sold Out |
| Total Postitions | 19 | +72.73% | 513,369 | +76.82% |
| Kestra Advisory Services, Llc | $412.00 | 1.34% | 94,021 | +94,021 | New | 2025-09-30 |
| Vanguard Group Inc | $323.00 | 1.05% | 73,797 | +38,420 | +108.6% | 2025-09-30 |
| Geode Capital Management, Llc | $186.00 | 0.61% | 42,406 | +10,250 | +31.88% | 2025-09-30 |
| Quantum Private Wealth, Llc | $105.00 | 0.34% | 24,000 | +14,000 | +140% | 2025-09-30 |
| Lpl Financial Llc | $89.00 | 0.29% | 20,250 | +8,075 | +66.32% | 2025-09-30 |
| Northern Trust Corp | $59.00 | 0.19% | 13,384 | +13,384 | New | 2025-09-30 |
| Virtu Financial Llc | $47.00 | 0.15% | 10,772 | -2,579 | -19.32% | 2025-09-30 |
| Bank Of America Corp /De/ | $33.00 | 0.11% | 7,455 | -46 | -0.61% | 2025-09-30 |
| Harbour Investments, Inc. | $10.00 | 0.03% | 2,275 | +2,275 | New | 2025-09-30 |
| Ubs Group Ag | $6.00 | 0.02% | 1,298 | -11,347 | -89.73% | 2025-09-30 |